Effects of combined elcatonin and alendronate treatment on the architecture and strength of bone in ovariectomized rats.

Ogawa, Koko; Hori, Masayuki; Takao, Ryoko; Sakurada, Toyozo

Ogawa, Koko; Hori, Masayuki; Takao, Ryoko; Sakurada, Toyozo.

Affiliation

Ogawa K; First Laboratory for Pharmacology, Institute for Life Science Research, Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni 410-2321, Japan. ogawa.kb@asahi-kasei.co.jp

J Bone Miner Metab ; 23(5): 351-8, 2005.

Article in En | MEDLINE | ID: mdl-16133684

Subject(s)

Alendronate/pharmacology; Bone Density/drug effects; Bone and Bones/drug effects; Calcitonin/analogs & derivatives; Alendronate/administration & dosage; Animals; Body Weight; Bone and Bones/metabolism; Calcitonin/administration & dosage; Calcitonin/pharmacology; Compressive Strength; Drug Therapy, Combination; Female; Femur/drug effects; Femur/pathology; Humans; Ovariectomy; Rats; Rats, Sprague-Dawley; Time Factors; Tomography, X-Ray Computed/methods

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone and Bones / Calcitonin / Bone Density / Alendronate Limits: Animals / Female / Humans Language: En Journal: J Bone Miner Metab Journal subject: METABOLISMO Year: 2005 Type: Article Affiliation country: Japan

Search on Google

XML

PubMed Links